Heartflow (HTFL) EBIT (2024 - 2025)
Heartflow's quarterly EBIT came in at $21.8 million in Q4 2025, down 13.38% year-on-year from $25.1 million in Q4 2024, and up 244.21% quarter-over-quarter from -$15.1 million in Q3 2025.
Heartflow has reported EBIT for 2 years, with the latest figure at $21.8 million in Q4 2025.
- For the quarter ending Q4 2025, EBIT fell 13.38% year-over-year to $21.8 million; the trailing twelve-month figure through Dec 2025 stood at $18.1 million (changed N/A YoY), and the FY2025 full-year result was -$24.5 million, down 22.54% from the prior year.
- EBIT for Q4 2025 stood at $21.8 million, up from -$15.1 million in the prior quarter.
- The five-year high for EBIT was $25.1 million in Q4 2024, with the low at -$15.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 245.88 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 121.45 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 102.95 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 32.07 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 24.83 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 80.47 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -17.05 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 7.42 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 16.85 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | 21.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.77 Mn |
| Sep 30, 2025 | -15.10 Mn |
| Jun 30, 2025 | -13.72 Mn |
| Dec 31, 2024 | 25.14 Mn |
| Sep 30, 2024 | -14.93 Mn |
| Jun 30, 2024 | -14.18 Mn |